Infective endocarditis in drug addicts: Role of HIV infection and the diagnostic accuracy of Duke criteria

Journal of Cardiovascular Medicine

Volumn 8, Issue 3, 2007, Pages 169-175

  Cecchi, Enrico ^a   Imazio, Massimo ^a   Tidu, Massimo ^a   Forno, Davide ^a   De Rosa, Francesco Giuseppe ^b   Dal Conte, Ivano ^b   Preziosi, Costantina ^b   Lipani, Filippo ^b   Trinchero, Rita ^a  

^a MARIA VITTORIA HOSPITAL   (Italy)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

Diagnosis; HIV infection; Infective endocarditis

Indexed keywords

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CAUSE OF DEATH; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DUKE CRITERIA; ECHOCARDIOGRAPHY; ENDOCARDIAL DISEASE; EVALUATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AORTIC VALVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; ITALY; MALE; MITRAL VALVE; MYCOSES; PROSPECTIVE STUDIES; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE, INTRAVENOUS; TRICUSPID VALVE;

EID: 33847096819     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000260824.14596.86     Document Type: Article

References (32)

1. Mirò JM, Del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003; 21:1-15.
2. Levine DP, Brown PD. Infections in injection drug users. In: Mandell GL, Douglas RG, Bennet JE, editors. Principles and practise of infectious diseases. Philadelphia, Pennsylvania: Churchill Livingstone; 2000. pp. 3112-3126.
3. Mirò JM, Gatel JM, Pujadas R, Escriva E, Argimon J, Fava P, et al. Right-sided endocarditis with Staphylococcus aureus. Ann Intern Med 1989; 110:497-498.
4. Sande MA, Lee BL, Millills J, Chambers HF. Endocarditis in intravenous drug users. I. In: Kaye D, editor. Infective endocarditis, 2nd edn. New York, New York: Raven Press; 1992. pp. 345-359.
5. Scheidegger C, Zimmerli W. Infectious complications in drug addicts: seven-years review of 269 hospitalized narcotic abusers in Switzerland. Rev Infect Dis 1989; 11:486-493.
6. Stoneburner RL, Des Jarlais DC, Benezra D, Gorelkin L, Sotheran JL, Friedman SR, et al. A larger spectrum of severe HIV-1 related disease in intravenous drug users in New York City. Science 1988; 242:916-919.
7. Fortun J, Navas E, Martinez-Beltran J, Perez-Molina J, Martin-Davila P, Guerrero A, Moreno S. Short-course therapy for right side endocarditis due to Staphylococcus aureus in drug abusers; claxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis 2001; 33:120-125.
8. Ribera E, Gomez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, et al. Effectiveness of cloxacillin with or without gentamicin in short-term therapy for right side Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med 1996; 125:969-974.
9. Heldman AW, Hartert TV, Ray SC, Daoud EG, Kowalski TE, Pompili VJ, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996; 101:68-76.
10. Nahas RB, Weinstein MP, Bartels J, Bocke DJ. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. J Infect Dis 1990; 162:967-970.
11. Pulvirenti JJ, Kerns E, Benson C, Lisowski J, Demarais P, Weinstein RA. Infective endocarditis in injection drug users: importance of human immunodeficiency serostatus and degree of immunosuppression. Clin Infect Dis 1996; 22:40-45.
12. Manoff SB, Vlahof D, Herskovicz A, Solomon L, Munoz A, Cohn S, et al. Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology 1996; 7:563-565.
13. Scheidegger C, Zimmerli W. Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users. AIDS 1996; 10:1407-1414.
14. Ribera E, Mirò JM, Cortes E, Cruceta A, Merce J, Marco F, et al. Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1998; 158:2043-2050.
15. Cicalini S, Forcina G, de Rosa FG. Infective endocarditis in patients with human immunodeficiency virus infection. J Infect 2001; 42:267-271.
16. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-209.
17. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-638.
18. Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med 1994; 96:211-219.
19. Cecchi E, Parrini I, Chinaglia A, Pomari F, Brusasco G, Bobbio M, et al. New diagnostic criteria for infective endocarditis. A study of sensitivity and specificity. Eur Heart J 1997; 18:1149-1156.
20. Gagliardi JP, Nettles RE, Mc Carty DE, Sanders LL, Corey GR, Sexton DJ. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. Clin Infect Dis 1998; 26:1165-1168.
21. Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamal F, Volot F, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 1999; 33:2023-2029.
22. Nettles RE, McCarty DE, Corey GR, Li J, Sexton DJ. An evaluation of the Duke criteria in 25 pathologically confirmed cases of prosthetic valve endocarditis. Clin Infect Dis 1997; 24:1185-1190.
23. Sekeres MA, Abrutyn E, Berlin JA, Kaye D, Kinman JL, Korzeniowski OM, et al. An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis. Clin Infect Dis 1997; 24:1185-1190.
24. Lamas CC, Eykin SJ. Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years. Heart 1998; 79:442-447.
25. Hoen B, Selton-Suty C, Danchin N, Weber M, Villemot JP, Mathieu P, et al. Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis 1995; 21:905-909.
26. Perez-Vazquez A, Farinas MC, Garcia-Palomo JD, Bernal JM, Revuelta JM, Gozales-Macias J. Evaluation of the Duke criteria in 93 episodes of prosthetic valve endocarditis: could sensitivity be improved? Arch Intern Med 2000; 160:1185-1191.
27. Rothman K, Greenland S. Modern epidemiology. Philadelphia, Pennsylvania: Lippincott-Raven Publishers; 1998.
28. Lamas CC, Eykin SJ. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis 1997; 25:713-719.
29. Cecchi E, Parrini I, Chinaglia A, Pomari F, Dal Conte I, Lipani F, et al. Complicazioni cardiache nella infezione HIV. G Ital Cardiol 1997; 27:917-924.
30. Berlin JA, Abrutyn E, Strom BL, Kinman JL, Levison ME, Korzeniowski OM, et al. Incidence of infective endocarditis in the Delaware valley, 1983-1990. Am J Cardiol 1995; 76:933-936.
31. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore) 1995; 74:324-339.
32. Valencia ME, Guinea J, Soriano V, Martinez ML, Moreno V, Laguna F, et al. Estudio de 164 episodios de endocarditis infecciosa en drogadictos: comparacion entre pacientes VIH positivos y negativos. Rev Clin Esp 1994; 194:535-539.